DAX24.379 -0,2%Est505.652 +0,1%MSCI World4.337 +0,2%Top 10 Crypto17,00 +3,3%Nas22.781 -0,3%Bitcoin104.473 +1,6%Euro1,1742 ±0,0%Öl64,36 +0,1%Gold3.886 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Plug Power A1JA81 Tesla A1CX3T HENSOLDT HAG000 Siemens Energy ENER6Y Novo Nordisk A3EU6F thyssenkrupp 750000 Alibaba A117ME BASF BASF11 D-Wave Quantum A3DSV9 Lufthansa 823212 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht mit leichten Verlusten ins Wochenende -- Wall Street schließt uneins - Dow mit Rekord -- BMW steigert US-Absatz -- NVIDIA, Tesla, Palantir, Plug Power, IONOS, Boeing, Rumble im Fokus
Top News
September 2025: Bitcoin, Ether & Co. - Monatsperformance der Kryptowährungen September 2025: Bitcoin, Ether & Co. - Monatsperformance der Kryptowährungen
Aktien teils deutlich eingebrochen: Warum sich Strategys Krypto-Strategie nicht für jeden Nachahmer lohnt Aktien teils deutlich eingebrochen: Warum sich Strategys Krypto-Strategie nicht für jeden Nachahmer lohnt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Abbott Laboratories Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
114,62 EUR +1,16 EUR +1,02 %
BMN
134,40 USD -0,18 USD -0,13 %
nachbörslich
BTT
Abbott Laboratories jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.198,21 Mrd. EUR

KGV14,81Div. Rendite1,98%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN850103

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS0028241000

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolABT

Abbott Laboratories Aktien News

DatumMeistgelesen
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
PR NewswireAbbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
PR NewswireAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
PR NewswireAbbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
PR NewswireAbbott Hosts Conference Call for First-Quarter Earnings
PR NewswireCanadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System
PR NewswireReal-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
PR NewswireAbbott Declares 401st Consecutive Quarterly Dividend
PR NewswireFDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve
PR NewswireNew Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again
PR NewswireAbbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey
PR NewswireAbbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+
PR NewswireAbbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Hosts Conference Call for Fourth-Quarter Earnings
PR NewswireAbbott to Present at J.P. Morgan Healthcare Conference
PR NewswireAbbott Increases Quarterly Dividend for 52nd Consecutive Year
PR NewswireLate-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump
PR NewswireParticipants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes
PR NewswireAbbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV
PR NewswireAbbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
PR NewswireAbbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program
PR NewswireNinety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem
PR NewswireLate-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care
PR NewswireLate-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves
PR NewswireAbbott Hosts Conference Call for Third-Quarter Earnings
PR NewswireAbbott Completes Acquisition of Bigfoot Biomedical
PR NewswireAbbott Declares 399th Consecutive Quarterly Dividend
PR NewswireAbbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets
PR NewswireAbbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets
PR NewswireCanadian First - Abbott's TactiFlex™ Ablation Catheter Used to Treat AFib
PR NewswireAbbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes
PR NewswireAbbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
PR NewswireAbbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker
PR NewswireAbbott Hosts Conference Call for Second-Quarter Earnings
PR NewswireAbbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹
PR NewswireAbbott Declares 398th Consecutive Quarterly Dividend
PR NewswireEuropean Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
PR NewswireAbbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
PR NewswireAbbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm
PR NewswireAbbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term

Abbott Laboratories News

Abbott Laboratories News: auf dieser Seite finden Sie alle Abbott Laboratories News und Nachrichten zur Abbott Laboratories Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Abbott Laboratories News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Abbott Laboratories News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.